Point-of-care diagnostic technology company Lumos Diagnostics (ASX:LDX) states that it has received a purchase order and shipped the product for FebriDx to iMedical.

Latest Video
New Stories
-
Lumos advances FebriDx sales with iMedical purchase order
May 14, 2025 - - Australian Biotech -
New Liberal leader Sussan Ley was responsible for major PBS reforms
May 13, 2025 - - Latest News -
New administrative order confirms the total move of NDIS to health
May 13, 2025 - - Latest News -
Trump's language on pricing matches Australia's reflex response to PBS criticism
May 13, 2025 - - Latest News -
Health stakeholders welcome the reappointment of Mark Butler
May 12, 2025 - - Latest News -
Pharma stocks rise in response to Trump's 'MFN' executive order
May 12, 2025 - - Latest News -
Lilly touts weight management results in new head-to-head study
May 12, 2025 - - Latest News